Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand

被引:18
作者
Aikphaibul, Puneyavee [1 ]
Theerawit, Tuangtip [2 ]
Sophonphan, Jiratchaya [3 ]
Wacharachaisurapol, Noppadol [2 ,4 ]
Jitrungruengnij, Nattapong [2 ]
Puthanakit, Thanyawee [1 ,2 ]
机构
[1] Chulalongkorn Univ, Dept Pediat, Fac Med, Bangkok, Thailand
[2] Chulalongkorn Univ, Ctr Excellence Pediat Infect Dis & Vaccines, Fac Med, Bangkok, Thailand
[3] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand
[4] Chulalongkorn Univ, Fac Med, Dept Pharmacol, Clin Pharmacokinet & Pharmacogen Res Unit, Bangkok, Thailand
关键词
bronchodilator; cirrhosis; community acquired; death; hospitalization; nosocomial infection; respiratory syncytial virus; CHILDREN; BURDEN; RSV; BRONCHIOLITIS; EPIDEMIOLOGY; PREVENTION; MORTALITY; INFANTS; DISEASE;
D O I
10.1111/irv.12793
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Aim To determine factors associated with severe hospitalized Respiratory syncytial virus (RSV)-associated LRTI and to describe management in tertiary care center. Methods Retrospective medical record review was conducted among children under 5 years old hospitalized with RSV-associated LRTI at King Chulalongkorn Memorial Hospital. Severe RSV-associated LRTI was defined as death, mechanical ventilator, or positive pressure ventilation use, prolonged hospitalization >7 days. Factors associated with severe RSV were analyzed using univariate and multivariate logistic regression. Results From January 2011 to December 2016, 427 children were hospitalized. Median age was 10 months (IQR 4.2-23.0). One hundred seventy-four (41%) patients had severe RSV (11 deaths, 56 mechanical ventilators, 19 positive pressure ventilation, and 88 prolonged hospitalization). Factors associated with severe RSV were chronic lung disease (aOR 15.16 [4.26-53.91]), cirrhosis/biliary atresia (aOR 15.01 [3.21-70.32]), congenital heart disease (aOR 5.11 [1.97-13.23]), chemotherapy (aOR 4.7 [1.34-16.56]), and pre-term (aOR 2.03 [1.13-3.67]). Oxygen therapy was mainly low flow oxygen delivery. 88% of cases received bronchodilator. Parenteral antibiotics were prescribed in 37.9% of cases. Conclusions Children with co-morbidities have higher risk of severe RSV-associated LRTI. More than two-third of patients received bronchodilator, of which was not recommended by American Academy of Pediatrics. The specific treatment and prevention for RSV are urgently needed.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 30 条
[1]   RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies [J].
Ali, Asad ;
Yousafzai, Mohammad Tahir ;
Waris, Rabbia ;
Jafri, Fatima ;
Aziz, Fatima ;
Abbasi, Imran Naeem ;
Zaidi, Anita .
JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) :1151-1157
[2]   Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries [J].
Bont L. ;
Checchia P.A. ;
Fauroux B. ;
Figueras-Aloy J. ;
Manzoni P. ;
Paes B. ;
Simões E.A.F. ;
Carbonell-Estrany X. .
Infectious Diseases and Therapy, 2016, 5 (3) :271-298
[3]   Epidemiology of RSV and hMPV in Belgium: a 10-year follow-up [J].
Cattoir, Lien ;
Vankeerberghen, Anne ;
Boel, An ;
Van Vaerenbergh, Kristien ;
De Beenhouwer, Hans .
ACTA CLINICA BELGICA, 2019, 74 (04) :229-235
[4]   The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta-analysis [J].
Chan, Markus ;
Park, John J. ;
Shi, Ting ;
Martinon-Torres, Federico ;
Bont, Louis ;
Nair, Harish .
JOURNAL OF GLOBAL HEALTH, 2017, 7 (02)
[5]   Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study [J].
Chatzis, Olga ;
Darbre, Stephanie ;
Pasquier, Jerome ;
Meylan, Pascal ;
Manuel, Oriol ;
Aubert, John David ;
Beck-Popovic, Maja ;
Masouridi-Levrat, Stavroula ;
Ansari, Marc ;
Kaiser, Laurent ;
Posfay-Barbe, Klara M. ;
Asner, Sandra A. .
BMC INFECTIOUS DISEASES, 2018, 18
[6]   Best practice in the prevention and management of paediatric respiratory syncytial virus infection [J].
Drysdale, Simon B. ;
Green, Christopher A. ;
Sande, Charles J. .
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2016, 3 (02) :63-71
[7]   Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease [J].
Figueras-Aloy J. ;
Manzoni P. ;
Paes B. ;
Simões E.A.F. ;
Bont L. ;
Checchia P.A. ;
Fauroux B. ;
Carbonell-Estrany X. .
Infectious Diseases and Therapy, 2016, 5 (4) :417-452
[8]   Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review [J].
French, Clare E. ;
McKenzie, Bruce C. ;
Coope, Caroline ;
Rajanaidu, Subhadra ;
Paranthaman, Karthik ;
Pebody, Richard ;
Nguyen-Van-Tam, Jonathan S. ;
Higgins, Julian P. T. ;
Beck, Charles R. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2016, 10 (04) :268-290
[9]   The Burden of Hospitalized Lower Respiratory Tract Infection due to Respiratory Syncytial Virus in Rural Thailand [J].
Fry, Alicia M. ;
Chittaganpitch, Malinee ;
Baggett, Henry C. ;
Peret, Teresa C. T. ;
Dare, Ryan K. ;
Sawatwong, Pongpun ;
Thamthitiwat, Somsak ;
Areerat, Peera ;
Sanasuttipun, Wichai ;
Fischer, Julie ;
Maloney, Susan A. ;
Erdman, Dean D. ;
Olsen, Sonja J. .
PLOS ONE, 2010, 5 (11)
[10]  
Geoghegan S, 2017, AM J RESP CRIT CARE, V195, P96, DOI [10.1164/rccm.201603-0658oc, 10.1164/rccm.201603-0658OC]